Product Information
OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0978 per EA under NDC 64980021005. Its NADAC has been published 180 times since Mar 15, 2023.
FDA first approved this application on May 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Oxybutynin Chloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980021005
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206121FDA Approved
5/27/2016
TE Code
AB
On Market Since
9/27/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 180 times since Mar 15, 2023, and over the history we have for it it has declined 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0978 per EA |
|---|---|
| All-time high | $0.1265 (Mar 15, 2023) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1089 |
| 52-week low | $0.0978 |
| Median price | $0.1078 |
| Average price | $0.1077 |
| Largest weekly change | +35.2% (Jun 19, 2024) |
| Weeks tracked | 180 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0978 per EA (NDC 64980021005), effective Aug 19, 2026.
How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 22.6%. It has been tracked across 180 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?
Since Mar 15, 2023, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.1265 (Mar 15, 2023), with a median of $0.1078 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN CL ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?
OXYBUTYNIN CL ER 10 MG TABLET (NDC 64980021005) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.